HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

Clidinium

HCID 2784
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
7020-55-5
Standard SMILES
C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2
InChIKey
HOOSGZJRQIVJSZ-UHFFFAOYSA-N
Molecular formula
C22H26NO3+
Average molar mass
352.4 g/mol
Monoisotopic mass
352.19126869

Overview

Clidinium is the ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. It has a role as an anti-arrhythmia drug, a parasympatholytic and an antispasmodic drug. It is an organic cation, a carboxylic ester and a quaternary ammonium ion. It is functionally related to a 3-quinuclidinol and a benzilic acid.

Names & identifiers

Preferred name
Clidinium
IUPAC
(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate
English name
clidinium
Molecular formula
C22H26NO3+
Molecular weight
352.45

Names & synonyms

clidinium7020-55-5N-Methyl quinuclidinyl benzilateClidinium ionClidinium cation3-hydroxy-1-methylquinuclidinium benzilate esterBO76JF850NCHEBI:3743DTXSID60453793-{[hydroxy(diphenyl)acetyl]oxy}-1-methyl-1-azoniabicyclo[2.2.2]octane3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane3-((hydroxy(diphenyl)acetyl)oxy)-1-methyl-1-azoniabicyclo(2.2.2)octane
Show more names
Clidinium bromide salt13C,2H3]-Clidinium bromide salt3-Hydroxy-1-methylquinuclidinium benzilate (ester)Quinuclidinium, 3-hydroxy-1-methyl-, benzilate (ester)1-Azoniabicyclo(2.2.2)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-
(1-methyl-1-azoniabicyclo(2.2.2)octan-8-yl) 2-hydroxy-2,2-di(phenyl)acetate(1-methyl-1-azoniabicyclo[2.2.2]octan-8-yl) 2-hydroxy-2,2-di(phenyl)acetate3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo(2.2.2)octaneRefChem:577717DTXCID4025379(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate[3H]clidiniumUNII-BO76JF850N

Properties

Computed structural properties

XLogP
3.3
Topological polar surface area
46.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
5
Heavy atoms
26
Formal charge
1
Complexity
482

Experimental & physicochemical properties

Human DrugsPharmaceuticals
Melting Point240-241 °C
Collision Cross Section181.98 Ų [M]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

FDA UNII
76 JF850N · BO76JF850N

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Regulatory InformationChemical: 1-Azoniabicyclo[2.2.2]octane, 3-[(hydroxydiphenylacetyl)oxy]-1-methyl-
Other Safety InformationEvaluation - Chemicals not considered for in depth evaluation - Not commercially active in Australia

Chemistry & industry

Pharmacology

PharmacodynamicsClidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract.
Mechanism of ActionInhibits muscarinic actions of acetylcholine at postganglionic parasympathetic neuroeffector sites primarily by inhibiting the M1 muscarinic receptors.
FDA Pharmacological Classification · 6 items

BO76JF850N

CLIDINIUM

Established Pharmacologic Class [EPC] - Anticholinergic

Physiologic Effects [PE] - Decreased Parasympathetic Acetylcholine Activity

Physiologic Effects [PE] - GI Motility Alteration

Physiologic Effects [PE] - Digestive/GI System Activity Alteration

MeSH Pharmacological ClassificationAgents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.

Uses & manufacturing

Use ClassificationPharmaceuticals
Additional notes · 1 item

DefinitionChEBI: The ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spa ms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome.

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
7020-55-5
PubChem CID
2784
DTXSID
DTXSID6045379
ChEMBL
CHEMBL620
ChEBI
CHEBI:3743
UNII
BO76JF850N
Nikkaji
J350.296A